Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
14.46
+0.04 (0.28%)
May 6, 2026, 3:04 PM CST

SHE:002007 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
26,42527,64930,81540,47141,28553,162
Market Cap Growth
-11.08%-10.27%-23.86%-1.97%-22.34%-31.01%
Enterprise Value
24,58024,56828,91739,27240,27350,356
Last Close Price
14.4615.1316.1420.8321.0126.79
PE Ratio
30.7929.4028.3327.3238.3640.93
Forward PE
25.8015.9319.3723.0528.4727.36
PS Ratio
5.896.027.047.589.1411.98
PB Ratio
1.942.072.233.023.385.87
P/TBV Ratio
2.322.472.673.674.096.54
P/FCF Ratio
39.0840.6238.3368.3173.2885.59
P/OCF Ratio
30.8231.4929.0930.0743.1337.11
PEG Ratio
2.505.165.165.165.165.16
EV/Sales Ratio
5.485.356.607.358.9211.35
EV/EBITDA Ratio
18.7417.5120.0918.9826.9228.25
EV/EBIT Ratio
23.7721.7524.5321.6932.9231.75
EV/FCF Ratio
36.3536.1035.9766.2971.4981.07
Debt / Equity Ratio
0.000.030.070.080.090.11
Debt / EBITDA Ratio
0.010.320.630.490.740.56
Debt / FCF Ratio
0.010.671.131.711.971.61
Net Debt / Equity Ratio
-0.28-0.29-0.32-0.25-0.21-0.26
Net Debt / EBITDA Ratio
-2.87-2.81-3.12-1.60-1.74-1.32
Net Debt / FCF Ratio
-5.56-5.80-5.58-5.59-4.61-3.78
Asset Turnover
0.280.290.270.350.340.41
Inventory Turnover
0.840.930.961.111.211.21
Quick Ratio
4.443.613.172.682.852.46
Current Ratio
6.574.934.073.613.763.09
Return on Equity (ROE)
6.61%7.34%8.48%13.75%11.73%16.94%
Return on Assets (ROA)
4.08%4.47%4.54%7.34%5.82%9.19%
Return on Invested Capital (ROIC)
9.12%10.24%10.45%15.57%13.09%24.42%
Return on Capital Employed (ROCE)
7.50%8.40%8.40%13.40%9.70%17.00%
Earnings Yield
3.25%3.40%3.53%3.66%2.61%2.44%
FCF Yield
2.56%2.46%2.61%1.46%1.36%1.17%
Dividend Yield
6.93%6.61%1.24%1.44%1.43%0.75%
Payout Ratio
147.37%144.78%43.00%38.04%37.12%43.43%
Buyback Yield / Dilution
0.13%0.16%-0.23%0.19%0.17%-0.59%
Total Shareholder Return
7.06%6.77%1.01%1.63%1.60%0.16%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.